This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.83% per year. These returns cover a period from January 1, 1988 through January 5, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
3 Top-Ranked U.S. Behemoths Witnessing Initial Breakthrough in 2026
by Nalak Das
MU, IBKR and MCHP are posting double-digit gains as early 2026 breakthroughs take shape.
IBKRPositive Net Change MUPositive Net Change MCHPPositive Net Change
fin-tech finance semiconductor
Is HOOD Stock's 105.6% One-Year Pop Just the Beginning or the Peak?
by Swayta Shah
Robinhood shares soar 105.6% in a year, fueled by crypto gains, global expansion and bold fintech bets. Is the rally over? Let's find out.
SCHWPositive Net Change IBKRPositive Net Change HOODNegative Net Change
banking cryptocurrency earnings-estimates-revisions fin-tech finance
JPMorgan's 2026 NII Guide Signals Resilience: Is JPM Stock a Buy Now?
by Swayta Shah
JPM projects 2026 NII of $103B despite rate cuts, banking on loan growth, card balances and deposit gains. Does this justify betting on the stock? Let's find out.
BACPositive Net Change JPMNegative Net Change CNegative Net Change
banking fin-tech finance
Robinhood: From Discount Broker to Fintech Powerhouse
by Andrew Rocco
Robinhood has evolved from a disruptive start-up to a multifaceted financial titan.
HOODNegative Net Change
fin-tech
Rocket Companies: Riding Rate Relief and Policy Tailwinds into 2026
by Bryan Hayes
Mortgage leaders like Rocket tend to thrive in rate-down cycles, rewarding patient investors.
RKTNegative Net Change
earnings fin-tech home-buying-apps inflation interest-rate investing real-estate
Pre-Q4 Earnings: Is SoFi Technologies Stock a Portfolio Must-Have?
by Shuvra Shankar Dey
SOFI heads into Q4 with sharp earnings and revenue growth expectations, but a recent pullback and elevated valuation put pressure on the bull case.
UPSTNegative Net Change SOFINegative Net Change XYZNegative Net Change
earnings-preview earnings-surprise fin-tech finance
Should You Buy Murphy USA (MUSA) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
MUSANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Visa Strengthens Crypto-to-Fiat Access Through Mercuryo Partnership
by Zacks Equity Research
V partners with Mercuryo to enable near-instant crypto-to-fiat conversions, boosting global digital payment access.
MANegative Net Change VNegative Net Change PYPLNegative Net Change
blockchain business-services cryptocurrency fin-tech payments
USA Compression Partners (USAC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
USACPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
After Golden Cross, Nicolet Bankshares (NIC)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NICNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines